CC
ADAP

Courier Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

Courier Capital’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,000
Closed -$9.36K – 356
2023
Q3 		$9.36K Buy
+12,000
New +$9.36K ﹤0.01% 340